{'fraction_non_alphanumeric': 0.023732470334412083, 'fraction_numerical': 0.003236245954692557, 'mean_word_length': 5.1866666666666665, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
A soft contact lens with embedded microtubes for sustained and self-adaptive drug delivery for glaucoma treatment.

Due to the physiological and anatomical constraints of the eye, ophthalmic drug delivery is challenging. When applied topically, less than 1% of administered ophthalmic drugs reach the aqueous humor. The delivery of a drug within an efficient therapeutic concentration, to the required site of action, for an extended period of time, is complicated. Herein, a novel type of contact lens device, with embedded microtubes as drug containers, is reported. This device can provide a simple, noninvasive, extended drug release up to 45 days, with higher bioavailability and lower risk for adverse effects. Another unique feature of the device is the release of drug triggered by stretch of the contact lens, indicating the possibility for achieving a self-adaptive drug release device for treating glaucoma patients.